Xiangyu Medical Hits Day Low at CNY 43.60 Amid Price Pressure

Xiangyu Medical Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced significant volatility today, closing down by 8.05% on July 13, 2026. The stock reached an intraday low of CNY 43.60, reflecting ongoing challenges within the company. Over the past week, Xiangyu Medical has seen a decline of 17.59%, while its monthly performance shows a decrease of 8.83%. Year-to-date, the stock has dropped 27.83%, contrasting sharply with the China Shanghai Composite, which has only seen a minor decline of 1.39% during the same period. Financial metrics indicate a concerning trend for Xiangyu Medical, with a return on equity (ROE) of 3.71% and a high price-to-earnings (P/E) ratio of 996.00, suggesting an expensive valuation relative to its earnings. The company has reported negative results for the last four consecutive quarters, with operating cash flow at its lowest point of CNY 155.86 million. These factors contribute to a challenging market position for Xiangyu Medical as it navigates through a difficult financial landscape.